Bulk Rituximab Monoclonal Antibody from Canada
Rituximab targets CD20 on B-cells for lymphoma and autoimmune treatment, a biotech-produced antibody. As an unmixed product not for retail, it fits HTS 3002.13.00 immunological products definition.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Ensure BLA (Biologics License Application) reference; provide glycosylation profile analysis; declare bulk quantity to affirm non-retail status